ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 329515 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 329515; 2) Community: the network communities that were significantly associated with the response to NSC 329515; 3) Molecule: the relationships between components within communities and NSC 329515; 4) MDR: the compounds that were significantly associated with the NSC 329515.

NSC Compound Enrichment Correlation
NSC 696661 (6R,6S)-2,4-Diamino-6-(3,4,5-trimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.0348993771550531 0.33549669
NSC 700418 Null 0.0348993771550531 0.10220027
NSC 726331 6-[2-Amino-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-methylened ioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.0348993771550531 0.33108836
NSC 728509 1-(2-Benzylthio-4-chloro-5-phenylcarbamoylbenzenesulfonyl)-3 -(2-oxobutane-3-ylideneimino)guanidine 0.0348993771550531 0.37373879
NSC 746608 Null 0.0348993771550531 0.29310885
NSC 750721 10-(3,4-dimethoxyphenyl)-6-(2-hydroxyethyl)-2,3,7,10-tetrahydro-[1,4]dioxino[2,3-g]furo[3,4-b]quinolin-9(6H)-one 0.0348993771550531 0.30941288
NSC 760200 Null 0.0348993771550531 0.18605699
NSC 381866 BAFILOMYCIN DERIV. 0.035202825328704 0.50226321
NSC 402717 Null 0.035202825328704 0.16869306
NSC 626167 Aplidazole C . TFA 0.035202825328704 0.25391162
Total:74  Current:52    [First] [Prev] [Next] [Last]